MedPath

SABAL SERRULATA COMPOSÉ

SABAL SERRULATA COMPOSÉ

Discontinued
DIN Number

02236436

Drug Class

Human

Market Date

Jan 5, 1998

Company
HC

dolisos canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02236436
AIG Number0831639002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid ,  Granules ,  Globules
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (8)

BARBERRY ROOTActive
Strength: 3 CH
Monograph: BARBERRY ROOT
BARIUM CARBONATEActive
Strength: 3 CH
Monograph: BARIUM CARBONATE
CONIUM MACULATUMActive
Strength: 3 CH
Monograph: CONIUM MACULATUM
PICRIC ACIDActive
Strength: 3 CH
Monograph: PICRIC ACID
PULSATILLAActive
Strength: 3 CH
Monograph: PULSATILLA
SAW PALMETTOActive
Strength: 3 CH
Monograph: SAW PALMETTO
SHEPHERDS PURSEActive
Strength: 3 CH
Monograph: SHEPHERDS PURSE
THUJA OCCIDENTALISActive
Strength: 3 CH
Monograph: THUJA OCCIDENTALIS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.